Nanogen Pharmaceutical develops Covid-19 vaccine: SAP ERP application, valued at more than VND 5,000 billion, the top 3 in the pharmaceutical industry when the revenue is “tiny”

Thời gian đọc: 2 phút

Covid-19 vaccine development and SAP ERP application in governance – Nanogen Pharmaceutical is valued at more than VND 5,000 billion, the top 3 in the pharmaceutical industry when the revenue is still “tiny”.

Covid-19 vaccine development and SAP ERP application in governance – Nanogen Pharmaceutical is valued at more than VND 5,000 billion, the top 3 in the pharmaceutical industry when the revenue is still “tiny”.

Nanogen has successfully tested the Covid-19 vaccine on mice and monkeys in June 2020 and will coordinate with the Military Medical Academy to officially recruit volunteers to participate in the first phase of Vietnam’s COVID-19 vaccine trial on December 10, 2020.

Sharing with the press, Mr. Ho Nhan, founder and general director of Nanogen Company, said that Nanogen had started researching to make the Covid-19 vaccine from the beginning of March 2020 when the epidemic broke out in China. In May 2020, the Ministry of Science and Technology issued Decision 1204 approving the “List of unexpected national-level scientific and technological tasks to prevent and control the Covid-19 epidemic”, assigning Nanogen to research on the treatment of Covid-19.

A week later, on May 15, the Ministry of Science and Technology continued to issue a decision to assign Nanogen Company to research the Covid-19. On May 21, Nanogen Company’s research project on a vaccine against Covid-19 was approved by the Ministry of Science and Technology, and assigned to the enterprise to organize it.

nanogen phat trien vacxin covid

Nanogen’s representative said that the price of the product on the market will not exceed 500,000 VND/dose so that everyone can access and they are working to have the vaccine included in the list of drugs covered by health insurance.

Each person from 12 to 75 years old needs two doses, 28 days apart. This is a flu vaccine line, so the drug has an immune effect for about a year and must be re-vaccinated.

At the beginning of 2018, Nanogen Pharmaceutical, one of the pioneering pharmaceutical enterprises in applying the world’s number 1 SAP ERP solution in operation and corporate governance.

nanogen ung dung sap erp

Dr. Ho Nhan, General Director of Nanogen Company emphasized: “I appreciate the timely implementation of Citek Technology Joint Stock Company, meeting Nanogen’s management needs such as standardizing the process in the fastest, most methodical and most professional way. SAP ERP system is built based on the process of integrating linked data for better management.”

In 2019, Nanogen increased its capital from 650 billion to 715 billion through a share offering to foreign shareholders, earning 463.6 billion dongs, corresponding to a company valuation of about 5,100 billion dongs (220 million dollars). The foreign ownership ratio in the company increased from 16.28% to 25.68%, of which all funds and individuals come from Korea.

VIEW MORE: PHARBACO OFFICIALLY OPERATES THE SAP S/4HANA INTELLIGENT ENTERPRISE ADMINISTRATION SYSTEM